Cerebrolysin in SAH (Subarachnoidal Haemorrhage)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

47 participants

Study Classification

OBSERVATIONAL

Study Start Date

2021-01-15

Study Completion Date

2023-01-10

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Subarachnoid haemorrhage often affects people in middle age and is associated with high mortality or neurological damage. In recent years, advances in surgical techniques have im-proved the mortality rate. However, there is still need for the research for the optimal possible final effect of treatment. In our study, we've decided to examine the effect of a multimodal approach including Cerebrolysin in the supportive treatment of patients. We've examined the supply of neuroprotective drugs and neuromonitoring.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Degradation of the Glycocalyx in Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage

NCT03706768

Aneurysmal Subarachnoid Hemorrhage

UNKNOWN NA

Prevention of Vasospasm in SAH Through CSF Treatment

NCT04490161

Subarachnoid Hemorrhage Subarachnoid Hemorrhage, Aneurysmal Vasospasm, Cerebral +1 more

RECRUITING NA

Sphenopalatine Block in Headache in Patients With Non-traumatic Subarachnoid Hemorrhage

NCT06735261

Subarachnoid Hemorrhage in Adult Patients

NOT_YET_RECRUITING NA

Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brain Injury Complicated by Subarachnoid Hemorrhage at Martinique University Hospital

NCT06560372

SAH (Subarachnoid Hemorrhage) Cerebral Vasospasm Moderate Traumatic Brain Injury +1 more

RECRUITING NA

Radiological Changes of Glymphatic-meningeal Lymphatic Drainage System After Subarachnoid Hemorrhage

NCT06444438

Subarachnoid Hemorrhage Lymphatic System Disorder Meningeal Lymphatic Vessels

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

SAH (Subarachnoid Hemorrhage)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

OTHER

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Cerebrolysin administration

No interventions assigned to this group

B

without Cerebrolysin administration

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age \>18 years old, diagnosis of SAH, treatment in ICU conditions

Exclusion Criteria

* age \<18 years, medical history of allergy to Cerebrolysin, acute renal failure, pregnancy, multi organ trauma, death within 48 hours after admission

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No